Almoosa Health Co. announced today the successful completion of retail subscription to its initial public offering for listing on Tadawul.
In a press statement, the company said that the retail subscription period, which run from Dec. 23-23, saw subscription to 395,986 shares at the final offer price of SAR 127 per share. The retail tranche was 408.71% covered, with a total value of SAR 1.4 billion.
A minimum of six shares will be allocated per investor, said the company, adding that allocation of rump shares will be on a pro-rata basis, at an average allocation factor of 3.33%.
The company also expects its shares to debut on the Main Market after fulfilling all legal and regulator requirements.
According to data available to Argaam, retail investors began, on Dec. 23, subscribiing to 2.66 million shares ofthe companyat SAR 127 per share, as determined through the book-building process.
The retail tranche accounts for 20% of the total offering.
In September, the Capital Market Authority (CMA) approved Almoosa’s request to float 13.29 million shares, or 30% of thepost-IPO capital, on theMain Market (TASI). The offeringalsorepresents 37.97% ofthepre-IPO capital, with a nominal value per share of SAR 10.
Almoosa Health started its operations in 1994 as a branch of Abdulaziz Abdullah Abdulwahab Al-Moosa Trading Establishment under the name “AlmoosaSpecialist Hospital (Al-Ahsa)”.
The company transformed into a limited liability company in 2018 and later became a closed joint-stock company in 2020.
Almoosa’s pre-IPO capital reaches SAR 350 million, divided into 35 million shares, at a nominal value of SAR 10 each. The company’s post-IPO capital will reach SAR 443.04 million, divided into 44.3 million shares.
Almoosa Health Co. announced today the successful completion of retail subscription to its initial public offering for listing on Tadawul.
In a press statement, the company said that the retail subscription period, which run from Dec. 23-23, saw subscription to 395,986 shares at the final offer price of SAR 127 per share. The retail tranche was 408.71% covered, with a total value of SAR 1.4 billion.
A minimum of six shares will be allocated per investor, said the company, adding that allocation of rump shares will be on a pro-rata basis, at an average allocation factor of 3.33%.
The company also expects its shares to debut on the Main Market after fulfilling all legal and regulator requirements.
According to data available to Argaam, retail investors began, on Dec. 23, subscribiing to 2.66 million shares ofthe companyat SAR 127 per share, as determined through the book-building process.
The retail tranche accounts for 20% of the total offering.
In September, the Capital Market Authority (CMA) approved Almoosa’s request to float 13.29 million shares, or 30% of thepost-IPO capital, on theMain Market (TASI). The offeringalsorepresents 37.97% ofthepre-IPO capital, with a nominal value per share of SAR 10.
Almoosa Health started its operations in 1994 as a branch of Abdulaziz Abdullah Abdulwahab Al-Moosa Trading Establishment under the name “AlmoosaSpecialist Hospital (Al-Ahsa)”.
The company transformed into a limited liability company in 2018 and later became a closed joint-stock company in 2020.
Almoosa’s pre-IPO capital reaches SAR 350 million, divided into 35 million shares, at a nominal value of SAR 10 each. The company’s post-IPO capital will reach SAR 443.04 million, divided into 44.3 million shares.
